Composition and method of decreasing renal ischemic damage

Details for Australian Patent Application No. 2008243175 (hide)

Owner Loma Linda University

Inventors Baldwin, Dalton D.

Agent Freehills

Pub. Number AU-A-2008243175

Parent 2005235306

Filing date 7 November 2008

Wipo publication date 4 December 2008

International Classifications

A61K 31/35 (2006.01) - having six-membered rings with one oxygen as the only ring hetero atom

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/497 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

Event Publications

27 November 2008 Complete Application Filed

4 December 2008 Application Open to Public Inspection

  Published as AU-A-2008243175

10 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008243176-Aneurysm treatment device

2008243174-Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use